IP Roundup

Premium

Rosetta Genomics of Rehovot, Israel, has received US Patent No. 7,592,441, "Liver cancer-related nucleic acids." The patent claims microRNAs, miRNA precursors, and associated nucleic acids that can be used for diagnosis, prognosis, and treatment of liver cancer. Also described are methods that can be used to identify modulators of the disease-associated polynucleotides. Methods and compositions for linear amplification and labeling of a targeted nucleic acid are also provided.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.